Methylphenidate effects on mice odontogenesis and connections with human odontogenesis.

The purpose of this study is to evaluate the effects of Methylphenidate exposure on mice odontogenesis and connect them by bioinformatics with human odontogenesis. Thirty-two pregnant Swiss mice were divided into treated group and control group, which received, respectively, 5 mg/kg of Methylphenidate and saline solution from the 5th to the 17th day of pregnancy. The mouse embryos tooth germs were analyzed through optical microscopy, and the data collected were analyzed statistically by Fisher's exact test. The presence and similarity of Methylphenidate-associated genes (Pharmgkb database) in both organisms and their interaction with dental development genes (AmiGO2 database) were verified on STRING database. Rates of tooth germ malformations were higher in treated than in control group (Control: 18; Treated: 27; p = 0.035). Mouse embryo malformations were connected with 238 interactions between 69 dental development genes with 35 Methylphenidate genes. Fourteen interactions for four Methylphenidate genes with four dental development genes, with human experimental data, were connected with mouse phenotype data. By homology, the interactions and conservation of proteins/genes may indicate similar outcomes for both organisms. The exposure to Methylphenidate during pregnancy affected odontogenesis in mouse embryos and may affect human odontogenesis. The study of malformations in mice, with a bioinformatics approach, could contribute to understanding of the Methylphenidate effect on embryo development. These results may provide novel hypotheses for further testing and reinforce the FDA protocol: as Methylphenidate is included in category C, its use during pregnancy should be considered if the benefits outweigh the risks.

Complete denture biofilm after brushing with specific denture paste, neutral soap and artificial saliva.

This study compared the levels of biofilm in maxillary and mandibular complete dentures and evaluated the number of colony-forming units (cfu) of yeasts, after using auxiliary brushing agents and artificial saliva. Twenty-three denture wearers with hyposalivation and xerostomia were instructed to brush the dentures 3 times a day during 3 weeks with the following products: Corega Brite denture dentifrice, neutral liquid soap, Corega Brite combined with Oral Balance (artificial saliva) or tap water. For biofilm quantification, the internal surfaces of the dentures were disclosed, photographed and measured using a software. For microbiological analysis, the biofilm was scrapped off, and the harvested material was diluted, sown in CHROMagar™ Candida and incubated at 37°C for 48 h. Data were analyzed statistically by two-way ANOVA and Tukey's test (α=0.05). Mandibular dentures presented a mean biofilm percentage (µ=26.90 ± 21.10) significantly greater than the maxillary ones (µ=18.0 ± 15.0) (p<0.05). Brushing using Corega Brite combined with Oral Balance (µ=15.87 ± 18.47) was more effective (p<0.05) than using the denture dentifrice (µ=19.47 ± 17.24), neutral soap (µ=23.90 ± 18.63) or tap water (control; µ=32.50 ± 20.68). For the microbiological analysis, the chi-square test did not indicate significant difference between the hygiene products for either type of denture. The more frequently isolated species of yeasts were C. albicans, C. tropicalis and C. glabrata. In conclusion, mandibular dentures had more biofilm formation than maxillary ones. Denture brushing with Corega Brite dentifrice combined with the use of Oral Balance was the most effective method for reduction of biofilm levels, but the use of products did not show difference in yeast cfu counts.

Complete denture biofilm after brushing with specific denture paste, neutral soap and artificial saliva

This study compared the levels of biofilm in maxillary and mandibular complete dentures and evaluated the number of colony-forming units (cfu) of yeasts, after using auxiliary brushing agents and artificial saliva. Twenty-three denture wearers with hyposalivation and xerostomia were instructed to brush the dentures 3 times a day during 3 weeks with the following products: Corega Brite denture dentifrice, neutral liquid soap, Corega Brite combined with Oral Balance (artificial saliva) or tap water. For biofilm quantification, the internal surfaces of the dentures were disclosed, photographed and measured using a software. For microbiological analysis, the biofilm was scrapped off, and the harvested material was diluted, sown in CHROMagar™ Candida and incubated at 37°C for 48 h. Data were analyzed statistically by two-way ANOVA and Tukey's test (α=0.05). Mandibular dentures presented a mean biofilm percentage (µ=26.90 ± 21.10) significantly greater than the maxillary ones (µ=18.0 ± 15.0) (p<0.05). Brushing using Corega Brite combined with Oral Balance (µ=15.87 ± 18.47) was more effective (p<0.05) than using the denture dentifrice (µ=19.47 ± 17.24), neutral soap (µ=23.90 ± 18.63) or tap water (control; µ=32.50 ± 20.68). For the microbiological analysis, the chi-square test did not indicate significant difference between the hygiene products for either type of denture. The more frequently isolated species of yeasts were C. albicans, C. tropicalis and C. glabrata. In conclusion, mandibular dentures had more biofilm formation than maxillary ones. Denture brushing with Corega Brite dentifrice combined with the use of Oral Balance was the most effective method for reduction of biofilm levels, but the use of products did not show difference in yeast cfu counts.

Este estudo comparou os níveis de biofilme em próteses totais maxilares e mandibulares, e analisou o número de unidades formadoras de colônias de leveduras, após o uso de agentes auxiliares da escovação e saliva artificial. Vinte e três usuários de próteses totais com hipossalivação e xerostomia foram orientados a escovar as dentaduras 3 vezes ao dia durante 3 semanas com os seguintes produtos: Corega Brite (dentifrício para prótese), sabonete líquido neutro, Corega Brite associado com o uso do Oral Balance (saliva artificial) ou água de torneira. Para a quantificação do biofilme, as superfícies internas das próteses totais foram evidenciadas, fotografadas e o biofilme quantificado com o auxílio de um software. Para a análise microbiológica, o biofilme foi removido por escovação, coletado, diluído, semeado em meio seletivo CHROMagar™ Candida e incubado a 37°C por 48 h. A análise de variância para dois fatores (p<0,05%) mostrou que as próteses mandibulares apresentaram uma média de porcentagem de biofilme (µ=26,90±21,10) maior que as maxilares (µ=18±15). O teste complementar de Tukey (0,46; p<5%) mostrou que a escovação com Corega Brite e Oral Balance (µ=15,87 ± 18,47) foi mais efetiva que o dentifrício (µ=19,47 ± 17,24), sabonete neutro (µ=23,90 ± 18,63), ou água de torneira (controle; µ=32,50 ± 20,68). Em relação á análise microbiológica, o teste de Qui-Quadrado não indicou diferença entre os produtos de higiene, para ambas as próteses. As espécies de leveduras mais comumente isoladas foram C. albicans, C. tropicalis e C. glabrata. Em conclusão, as próteses mandibulares apresentaram mais biofilme do que as maxilares. Além disso, a escovação das próteses com o Corega Brite associado ao uso do Oralbalance foi o método mais efetivo na redução dos níveis de biofilme, entretanto o uso dos produtos não demonstrou diferença no número de ufc de leveduras.

Estudo populacional relacionado à saúde geral e uso de medicamentes em idosos não institucionalizados e desdentados totais / Population survey related to general health and use of medication in one group of non-institutionalized complete edentulous elderly

O objetivo deste estudo foi conhecer o perfil de saúde geral, uso de medicamentos e sintomas bucais auto-referidos em um grupo de 307 idosos desdentados totais. Foram entrevistados 215 mulheres (70%) e 92 (30%) homens com idades entre 60 e 91 anos(média de 69) utilizando-se um questionário de saúde. A maioria dos idosos (88%) apresentava pelo menos uma doença pesquisada, sendo a hipertensão (56%) a mais comum. Outros problemas prevaleceram como artropatias (32%), osteoporose (28%),cardiopatias (27%) e diabetes (17%). Na amostra, 85% dos idosos consumiam algum tipo de medicamento com média de 2,92 tipos por indivíduo. Destacaram-se o uso dos anti-hipertensivos (38%), diuréticos (28%), complementos vitamínicos (20%), antiinflamatórios não-esteroidais (18%), hormônios de reposição (12%), vasodilatadoresperiféricos (11%), anticoagulantes (11%), hipoglicemiantes (11%), ansiolíticos (9%) e antidepressivos (7%) respectivamente. A mulheres tenderam a consumir mais medicamentos que os homens (88% vs. 76%). O grupo apresentou alta freqüência de doenças crônicas predominando as condições cardiovasculares e reumáticas, sendotambém freqüente a necessidade do tratamento medicamentoso cardiovascular e de controle da dor ou inflamação. A incidência de doenças crônicas, uso de medicamentos e politerapia medicamentosa foi maior nas mulheres que predominaram neste segmento populacional. A xerostomia foi o sintoma bucal mais comum, relatado por 93% dos usuários de medicamentos e sua possível causa era geralmente desconhecida pelo idoso